Johnson & Johnson (JNJ.DE)

EUR 136.92

(-0.41%)

Operating Income Summary of Johnson & Johnson

  • Johnson & Johnson's latest annual operating income in 2023 was 23.4 Billion USD , up 45.63% from previous year.
  • Johnson & Johnson's latest quarterly operating income in 2024 Q1 was 6.15 Billion USD , up 20.96% from previous quarter.
  • Johnson & Johnson reported an annual operating income of 17.05 Billion USD in 2022, down -6.85% from previous year.
  • Johnson & Johnson reported an annual operating income of 18.3 Billion USD in 2021, up 39.65% from previous year.
  • Johnson & Johnson reported a quarterly operating income of 5.27 Billion USD for 2024 Q3, down -21.15% from previous quarter.
  • Johnson & Johnson reported a quarterly operating income of 6.69 Billion USD for 2024 Q2, up 8.7% from previous quarter.

Annual Operating Income Chart of Johnson & Johnson (2023 - 1989)

Historical Annual Operating Income of Johnson & Johnson (2023 - 1989)

Year Operating Income Operating Income Growth
2023 23.4 Billion USD 45.63%
2022 17.05 Billion USD -6.85%
2021 18.3 Billion USD 39.65%
2020 13.11 Billion USD -13.27%
2019 15.11 Billion USD -14.33%
2018 17.64 Billion USD -7.15%
2017 19 Billion USD 2.13%
2016 18.6 Billion USD -9.36%
2015 20.52 Billion USD 3.95%
2014 19.74 Billion USD -6.39%
2013 21.09 Billion USD 32.24%
2012 15.95 Billion USD 8.92%
2011 14.64 Billion USD 13.25%
2010 12.93 Billion USD -25.69%
2009 17.4 Billion USD 7.38%
2008 16.2 Billion USD -6.67%
2007 17.36 Billion USD 30.72%
2006 13.28 Billion USD -8.94%
2005 14.58 Billion USD 6.82%
2004 13.65 Billion USD 6.37%
2003 12.83 Billion USD 24.54%
2002 10.3 Billion USD 10.95%
2001 9.29 Billion USD 17.64%
2000 7.89 Billion USD 19.27%
1999 6.62 Billion USD 15.11%
1998 5.75 Billion USD 34.76%
1997 4.26 Billion USD -6.71%
1996 4.57 Billion USD 13.46%
1995 4.03 Billion USD 21.59%
1994 3.31 Billion USD 23.72%
1993 2.68 Billion USD 14.97%
1992 2.33 Billion USD 44.67%
1991 1.61 Billion USD -20.9%
1990 2.03 Billion USD 25.57%
1989 1.62 Billion USD 7.2%

Peer Operating Income Comparison of Johnson & Johnson

Name Operating Income Operating Income Difference
Bayer Aktiengesellschaft -150 Million EUR 15706.0%
Sanofi 7.87 Billion EUR -197.257%